Healthcare -
Biotechnology - NASDAQ - US
$ 1.02
-2.17 %
$ 57.6 M
Market Cap
-0.58
P/E
PRLD - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities PRLD - Prelude Therapeutics Incorporated
-120 K
LAST VALUE
-7.11%
2 YEAR CAGR
-0.08%
5 YEAR CAGR
0.00%
10 YEAR CAGR